N
Noriaki Sunaga
Researcher at Gunma University
Publications - 143
Citations - 3908
Noriaki Sunaga is an academic researcher from Gunma University. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 32, co-authored 133 publications receiving 3477 citations.
Papers
More filters
Journal ArticleDOI
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,S. Tanaka,T. Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takahito Nakajima,Masatomo Mori +12 more
TL;DR: L-type amino acid transporter 1 expression is a promising pathological factor to predict the prognosis in patients with resectable stage I–III NSCLC and was significantly associated with lymph node metastasis and disease stage.
Journal ArticleDOI
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations
Satoshi Morita,Isamu Okamoto,Kunihiko Kobayashi,Koichi Yamazaki,Hajime Asahina,Akira Inoue,Koichi Hagiwara,Noriaki Sunaga,Noriko Yanagitani,Toyoaki Hida,Kimihide Yoshida,Tomonori Hirashima,Kosei Yasumoto,Kenji Sugio,Tetsuya Mitsudomi,Masahiro Fukuoka,Toshihiro Nukiwa +16 more
TL;DR: Gefitinib monotherapy confers substantial clinical benefit in terms of progression-free survival and overall survival in non–small cell lung cancer patients with EGFR mutations.
Journal ArticleDOI
Metabolic activity by 18 F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
Kyoichi Kaira,Tetsuya Higuchi,Ichiro Naruse,Yukiko Arisaka,Azusa Tokue,Bolag Altan,Satoshi Suda,Akira Mogi,Kimihiro Shimizu,Noriaki Sunaga,Takeshi Hisada,Shigehisa Kitano,Hideru Obinata,Takehiko Yokobori,Keita Mori,Masahiko Nishiyama,Yoshihito Tsushima,Takayuki Asao +17 more
TL;DR: Metabolic response by 18F–FDG was effective in predicting efficacy and survival at 1 month after nivolumab treatment and Multivariate analysis confirmed that 18F-FDG uptake after administration of nivlumab was an independent prognostic factor.
Journal ArticleDOI
l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms
Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Shigebumi Tanaka,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori +12 more
TL;DR: It is suggested that overexpression of LAT1 and CD98 has an important role to play in the metastatic process of variable human neoplasms and was closely correlated with CD98 expression, angiogenesis, and cell proliferation.
Journal ArticleDOI
Clinicopathologic Significance of the Mutations of the Epidermal Growth Factor Receptor Gene in Patients with Non ^ Small Cell Lung Cancer
Yoshio Tomizawa,Hironobu Iijima,Noriaki Sunaga,Koji Sato,Atsushi Takise,Yoshimi Otani,S. Tanaka,Tatsuo Suga,Ryusei Saito,Tamotsu Ishizuka,Kunio Dobashi,John D. Minna,Takashi Nakajima,Masatomo Mori +13 more
TL;DR: These results in Japanese (East Asian) patients indicated that EGFR mutation plays an important role in pathogenesis of lung adenocarcinoma.